PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
EW vs. NVNO
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


EWNVNO
YTD Return11.55%-1.56%
1Y Return-3.45%25.25%
3Y Return (Ann)-3.50%-6.71%
5Y Return (Ann)7.06%-38.33%
Sharpe Ratio-0.110.31
Daily Std Dev28.37%86.82%
Max Drawdown-52.78%-98.02%
Current Drawdown-34.91%-96.14%

Fundamentals


EWNVNO
Market Cap$52.02B$68.98M
EPS$2.30-$1.91
Revenue (TTM)$6.14B$0.00
Gross Profit (TTM)$4.30B$0.00
EBITDA (TTM)$1.92B-$25.02M

Correlation

-0.50.00.51.00.1

The correlation between EW and NVNO is 0.13, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

EW vs. NVNO - Performance Comparison

In the year-to-date period, EW achieves a 11.55% return, which is significantly higher than NVNO's -1.56% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


-100.00%-50.00%0.00%50.00%100.00%December2024FebruaryMarchAprilMay
85.84%
-96.14%
EW
NVNO

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Edwards Lifesciences Corporation

enVVeno Medical Corporation

Risk-Adjusted Performance

EW vs. NVNO - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Edwards Lifesciences Corporation (EW) and enVVeno Medical Corporation (NVNO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


EW
Sharpe ratio
The chart of Sharpe ratio for EW, currently valued at -0.11, compared to the broader market-2.00-1.000.001.002.003.004.00-0.11
Sortino ratio
The chart of Sortino ratio for EW, currently valued at 0.04, compared to the broader market-4.00-2.000.002.004.006.000.04
Omega ratio
The chart of Omega ratio for EW, currently valued at 1.01, compared to the broader market0.501.001.501.01
Calmar ratio
The chart of Calmar ratio for EW, currently valued at -0.06, compared to the broader market0.002.004.006.00-0.06
Martin ratio
The chart of Martin ratio for EW, currently valued at -0.18, compared to the broader market-10.000.0010.0020.0030.00-0.18
NVNO
Sharpe ratio
The chart of Sharpe ratio for NVNO, currently valued at 0.31, compared to the broader market-2.00-1.000.001.002.003.004.000.31
Sortino ratio
The chart of Sortino ratio for NVNO, currently valued at 1.11, compared to the broader market-4.00-2.000.002.004.006.001.11
Omega ratio
The chart of Omega ratio for NVNO, currently valued at 1.13, compared to the broader market0.501.001.501.13
Calmar ratio
The chart of Calmar ratio for NVNO, currently valued at 0.27, compared to the broader market0.002.004.006.000.27
Martin ratio
The chart of Martin ratio for NVNO, currently valued at 1.20, compared to the broader market-10.000.0010.0020.0030.001.20

EW vs. NVNO - Sharpe Ratio Comparison

The current EW Sharpe Ratio is -0.11, which is lower than the NVNO Sharpe Ratio of 0.31. The chart below compares the 12-month rolling Sharpe Ratio of EW and NVNO.


Rolling 12-month Sharpe Ratio-0.60-0.40-0.200.000.200.400.600.80December2024FebruaryMarchAprilMay
-0.11
0.31
EW
NVNO

Dividends

EW vs. NVNO - Dividend Comparison

Neither EW nor NVNO has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

EW vs. NVNO - Drawdown Comparison

The maximum EW drawdown since its inception was -52.78%, smaller than the maximum NVNO drawdown of -98.02%. Use the drawdown chart below to compare losses from any high point for EW and NVNO. For additional features, visit the drawdowns tool.


-100.00%-80.00%-60.00%-40.00%-20.00%December2024FebruaryMarchAprilMay
-34.91%
-96.14%
EW
NVNO

Volatility

EW vs. NVNO - Volatility Comparison

The current volatility for Edwards Lifesciences Corporation (EW) is 5.79%, while enVVeno Medical Corporation (NVNO) has a volatility of 16.12%. This indicates that EW experiences smaller price fluctuations and is considered to be less risky than NVNO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%25.00%30.00%December2024FebruaryMarchAprilMay
5.79%
16.12%
EW
NVNO

Financials

EW vs. NVNO - Financials Comparison

This section allows you to compare key financial metrics between Edwards Lifesciences Corporation and enVVeno Medical Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items